Submission Details
| 510(k) Number | K200754 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 23, 2020 |
| Decision Date | June 02, 2022 |
| Days to Decision | 801 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
K200754 is an FDA 510(k) clearance for the Hemosure Accu-Reader A100, a Automated Occult Blood Analyzer (Class II — Special Controls, product code OOX), submitted by W.H.P.M., Inc. (Irwindale, US). The FDA issued a Cleared decision on June 2, 2022, 801 days after receiving the submission on March 23, 2020. This device falls under the Hematology review panel. Regulated under 21 CFR 864.6550.
| 510(k) Number | K200754 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 23, 2020 |
| Decision Date | June 02, 2022 |
| Days to Decision | 801 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
| Product Code | OOX — Automated Occult Blood Analyzer |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.6550 |
| Definition | The Automated Test System Is Intended For The Qualitative Detection Of Fecal Occult Blood In Feces By Professional Laboratories. The Automated Test Is Used For The Determination Of Gastrointestinal Bleeding. |